Here’s good news for India’s traditional medicine system. A professor from Banaras Hindu University (BHU) has secured a US patent for his Ayurvedic medicine that claims to slow down the ageing process, works in prevention and management of senile dementia and age-related neurodegenerative changes. A Chennai-based firm is all set to start commercial production of the medicine.
Prof. G.P. Dubey, professor emeritus of the faculty of ayurveda, Institute of Medical Sciences (IMS)-BHU, who has obtained the patent on products prepared out of three medicinal plants — Bacopa monnieri, Dioscorea bulbifera, and Hippophae rhamnoides — said that the medicine would be affordable for the common man.
The professor told reporters in Varanasi that global attention is gradually shifting to traditional forms of medicine to meet the health care needs of the general population and India has a rich tradition in the Ayurveda, Siddha and Unani systems of medicine.
He said that several multinational companies were trying to exploit the rich national heritage by patenting Indian knowledge.
The professor disclosed that Arvind Remedies Limited, a Chennai-based company, has entered into an agreement with the BHU for exporting the drug and the company will pay royalty to the BHU and other collaborative organisations.